102 Annual Pap Smear Screening Database Maintenance Project
1 other identifier
observational
300,000
1 country
1
Brief Summary
This study aimed to evaluate the subsequent cancer risks, including gynecological cancers and malignancies at other sites, after the detection of screening positives and the diagnosis for primary cervical cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1995
CompletedFirst Submitted
Initial submission to the registry
February 10, 2014
CompletedFirst Posted
Study publicly available on registry
February 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedAugust 17, 2017
August 1, 2017
25.9 years
February 10, 2014
August 14, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Time to the cancer diagnosis or the recurrence, the death, or the last date of follow-up, whichever came first
up to 25 years
Study Arms (1)
Entire Taiwan women
Eligibility Criteria
Women attended screening and found abnormal results, and women who were diagnosed as cervical cancer were the main study population. Women who did not attend screening for at least 6 years were also included.
You may qualify if:
- Citizens in Taiwan
- Women who attended screening, or who were diagnosed as cervical cancer
- Women who did not attend screening for at least 6 years
You may not qualify if:
- Women died before the follow-up initiation
- Women who had received hysterectomy before the follow-up initiation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taiwan Cervical Cancer Prevention Monitoring Center
Taipei, 10055, Taiwan
Related Publications (1)
Tai YJ, Chen YY, Hsu HC, Chiang CJ, You SL, Chen CA, Cheng WF; Taiwan Cervical Cancer Control Task Force. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study. J Gynecol Oncol. 2018 Jul;29(4):e55. doi: 10.3802/jgo.2018.29.e55. Epub 2018 Mar 20.
PMID: 29770625DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Chi-An Chen, MD
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 25 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2014
First Posted
February 14, 2014
Study Start
January 1, 1995
Primary Completion
December 1, 2020
Last Updated
August 17, 2017
Record last verified: 2017-08